Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Leukemia, Myeloid, Acute × Vitamin D × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 9 Prostatic Neoplasms 2 Obesity 2 Vitamin D Deficiency 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Peripheral Nervous System Diseases 1 Neurofibromatosis 1 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Kidney Neoplasms 1 Helicobacter Infections 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

Cytarabine 177 Azacitidine 128 Cyclophosphamide 121 fludarabine phosphate 95 fludarabine 84 Busulfan 84 venetoclax 82 Mycophenolic Acid 72 Whole-Body Irradiation 68 Peripheral Blood Stem Cell Transplantation 66 Tacrolimus 63 Decitabine 56 Filgrastim 50 Melphalan 46 Idarubicin 46 Cyclosporine 46 Granulocyte Colony-Stimulating Factor 44 Daunorubicin 44 Methotrexate 42 Antilymphocyte Serum 38 Etoposide 37 Clofarabine 36 Gemtuzumab 32 Mitoxantrone 30 Thiotepa 28 Stem Cell Transplantation 28 CPX-351 26 thymoglobulin 23 Radiotherapy 23 Injections 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02341495 2020-02-27

EXJADE

Loyola University

Phase 2 Terminated

4 enrolled 4 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡